About Kevin Bitterman
Form D filings for Chroma Medicine in 2023 list Kevin Bitterman as director.
Kevin Bitterman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Bitterman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Bitterman works with at each company, as listed on that company's latest Form D.
Chroma Medicine, Inc. · Form D/A, Sep 1, 2023
BC
Bihua Chen
Director
GG
George Golumbeski
Director
BK
Brett Kaplan
Chief Financial Officer
VM
Vic Myer
Executive officer
MK
Michael Kelly
Director
CB
Catherine Stehman-Breen
Executive officer and director
PP
Paola Pozzi
Director
JM
Jeff Marrazzo
Director
TC
Thomas Cahill
Director